Fund group builds Catheter Precision (NASDAQ: VTAK) stake using convertible preferred

Rhea-AI Filing Summary

Catheter Precision, Inc. (VTAK) is reporting that a group of investment entities and individuals, including C/M Capital Master Fund, LP, WVP Emerging Manager Onshore Fund LLC, C/M Capital Partners, LP, Thomas Walsh and Jonathan Juchno, has filed a Schedule 13G regarding its position in the company’s common stock.

The Reporting Persons collectively report beneficial ownership of 1,597,328 shares of common stock, representing 9.99% of the outstanding class. This total includes 159,574 shares of common stock issuable upon conversion of convertible preferred stock held by the funds. Voting and dispositive power over these shares is reported on a shared basis among the group, while Messrs. Walsh and Juchno state that they disclaim beneficial ownership of shares held by the funds.

Key Figures

Shares beneficially owned (group): 1,597,328 shares Percent of class (group): 9.99% Shares issuable upon conversion: 159,574 shares +2 more

5 metrics

Shares beneficially owned (group) 1,597,328 shares Beneficial ownership reported by the Reporting Persons for Catheter Precision, Inc. common stock

Percent of class (group) 9.99% Percent of Catheter Precision, Inc. common stock reported as beneficially owned

Shares issuable upon conversion 159,574 shares Common stock issuable upon conversion of convertible preferred stock included in beneficial ownership

Shares beneficially owned per fund 878,451 shares Beneficial ownership reported by each of C/M Capital Master Fund, LP and WVP Emerging Manager Onshore Fund LLC

Percent of class per fund 5.49% Percent of Catheter Precision, Inc. common stock beneficially owned by each of C/M Master Fund and WVP Fund

Key Terms

beneficial ownership, convertible preferred stock, shared voting power, shared dispositive power, +1 more

5 terms

beneficial ownership financial

"The information required by Item 4(a) is set forth in Row 9..."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

convertible preferred stock financial

"Includes 159,574 shares of Common Stock issuable upon conversion of convertible preferred stock."

Convertible preferred stock is a special class of company shares that pays priority, usually fixed, payments to holders and can be exchanged later for a set number of common shares. It matters to investors because it combines steady income and added protection with the chance to share in a company’s upside; think of it as a hybrid between a bond that pays regularly and an option to convert into growth-oriented stock, where the conversion rules influence both potential gains and how much common shareholders’ ownership may be reduced.

shared voting power financial

"6 | Shared Voting Power 1,597,328.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"8 | Shared Dispositive Power 1,597,328.00"

Schedule 13G regulatory

"This statement is filed by... the "Reporting Persons.""

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of Catheter Precision, Inc. (VTAK) does the reporting group hold?

The reporting group states that it beneficially owns 9.99% of Catheter Precision, Inc.’s common stock. This percentage is based on 1,597,328 shares reported as beneficially owned, including shares issuable upon conversion of convertible preferred stock.

How many Catheter Precision (VTAK) shares does the C/M Capital group report owning?

The Reporting Persons collectively report beneficial ownership of 1,597,328 shares of Catheter Precision, Inc. common stock, including 159,574 shares issuable upon conversion of convertible preferred stock held by the funds.

Which entities filed the Schedule 13G for Catheter Precision, Inc. (VTAK)?

The Schedule 13G was filed by C/M Capital Master Fund, LP, WVP Emerging Manager Onshore Fund LLC, C/M Capital Partners, LP, Thomas Walsh, and Jonathan Juchno, collectively referred to as the Reporting Persons.

What positions do C/M Capital Master Fund and WVP Emerging Manager Onshore Fund report in VTAK?

Each of C/M Capital Master Fund, LP and WVP Emerging Manager Onshore Fund LLC reports beneficial ownership of 878,451 shares of Catheter Precision, Inc. common stock, representing 5.49% of the class, with shared voting and dispositive power over these shares.

Does the Catheter Precision (VTAK) 13G include convertible preferred stock?

Yes. The beneficial ownership reported includes 159,574 shares of common stock issuable upon conversion of convertible preferred stock held by the funds, which are counted within the 1,597,328 total shares reported.

Do Thomas Walsh and Jonathan Juchno claim full beneficial ownership of the VTAK shares?

Thomas Walsh and Jonathan Juchno are managing members of the general partner of C/M Capital Partners, but they disclaim beneficial ownership of the shares of common stock (and underlying convertible preferred) held by the funds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 04:06 PM Accepted by SEC EDGAR 08/21/2026 - 04:05 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Catheter Precision, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

74933X708

(CUSIP Number)

08/16/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 74933X708

1

Names of Reporting Persons

C/M Capital Master Fund, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 878,451.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 878,451.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

878,451.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.49 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Includes 159,574 shares of Common Stock (as defined in Item 2(a)) issuable upon conversion of convertible preferred stock.

SCHEDULE 13G

CUSIP Number(s): 74933X708

1

Names of Reporting Persons

WVP Emerging Manager Onshore Fund LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 878,451.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 878,451.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

878,451.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.49 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Includes 159,574 shares of Common Stock issuable upon conversion of convertible preferred stock.

SCHEDULE 13G

CUSIP Number(s): 74933X708

1

Names of Reporting Persons

C/M Capital Partners, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,597,328.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,597,328.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,597,328.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Includes 159,574 shares of Common Stock issuable upon conversion of convertible preferred stock.

SCHEDULE 13G

CUSIP Number(s): 74933X708

1

Names of Reporting Persons

Thomas Walsh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,597,328.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,597,328.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,597,328.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Includes 159,574 shares of Common Stock issuable upon conversion of convertible preferred stock.

SCHEDULE 13G

CUSIP Number(s): 74933X708

1

Names of Reporting Persons

Jonathan Juchno

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,597,328.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,597,328.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,597,328.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Includes 159,574 shares of Common Stock issuable upon conversion of convertible preferred stock.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Catheter Precision, Inc.
(b)	Address of issuer's principal executive offices: 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708
Item 2.
(a)	Name of person filing: This statement is filed by: (i) C/M Capital Master Fund, LP, a Delaware limited partnership ("C/M Master Fund"); (ii) WVP Emerging Manager Onshore Fund LLC, Delaware limited liability company ("WVP Fund" and together with C/M Master Fund, the "Funds"); (iii) C/M Capital Partners, LP, a Delaware limited partnership ("C/M Capital Partners"); (iv) Thomas Walsh ("Mr. Walsh"); and (v) Jonathan Juchno ("Mr. Juchno"). The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The shares of common stock, par value $0.0001 per share (the "Common Stock"), of Catheter Precision, Inc. (the "Issuer") reported herein are held by (and shares of Common Stock underlying convertible preferred stock held by) the Funds. C/M Capital Partners is the investment manager to the Funds. Messrs. Walsh and Juchno are the managing members of the general partner of C/M Capital Partners. Messrs. Walsh and Juchno disclaim beneficial ownership of any shares of Common Stock held by (and shares of Common Stock underlying convertible preferred stock held by) the Funds.
(b)	Address or principal business office or, if none, residence: The address of the business office of each of the Reporting Persons is 1111 Brickell Ave, Suite 2920, Miami, FL 33131.
(c)	Citizenship: Each of C/M Master Fund and C/M Capital Partners is a limited partnership organized under the laws of the State of Delaware. WVP Fund is a limited liability company organized under the laws of the State of Delaware. Each of Messrs. Walsh and Juchno is a citizen of the United States.
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 74933X708
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(ii) Shared power to vote or to direct the vote: The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iii) Sole power to dispose or to direct the disposition of: The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iv) Shared power to dispose or to direct the disposition of: The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

C/M Capital Master Fund, LP

Signature:	/s/ Thomas Walsh
Name/Title:	By: C/M Global GP, LLC, General Partner, By: Thomas Walsh, Manager
Date:	08/21/2025

WVP Emerging Manager Onshore Fund LLC

Signature:	/s/ Thomas Walsh
Name/Title:	By: Cavalry Fund I GP LLC, General Partner, By: Thomas Walsh, Manager
Date:	08/21/2025

C/M Capital Partners, LP

Signature:	/s/ Thomas Walsh
Name/Title:	Thomas Walsh, Partner
Date:	08/21/2025

Thomas Walsh

Signature:	/s/ Thomas Walsh
Name/Title:	Thomas Walsh, individually
Date:	08/21/2025

Jonathan Juchno

Signature:	/s/ Jonathan Juchno
Name/Title:	Jonathan Juchno, individually
Date:	08/21/2025